JPRN-jRCT2080222478未知3 期
A phase III long-term study to evaluate the safety and efficacy of TAC-202 in patients with chronic idiopathic urticaria and pruritus accompanied by skin diseases
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Subjects with a documented history of chronic urticaria for at least 4 weeks prior to consent acquisition.
- •Subjects with itching associated with skin disease.
排除标准
- •Subjects with any of the following diseases that may hinder efficacy evaluation.
- •Vascular edema/ Cholinergic urticarial/ Mechanical urticaria (chill, sunlight, warmth/heat, delayed pressure, water, vibration)/ Aspirin-induced urticarial/ Urticaria associated with vasculitis or collagen disorder/ Urticaria of known origin/ Urticaria related to the thyroid gland/ Urticaria pigmentosa/ Food-dependent motofacient anaphylaxis/ Schnitzler syndrome/ CAPS (cryopyrin associated periodic syndrome)/ Psoriasis/ Ichthyosis
- •Subjects who previously developed anaphylaxis to antihistamine drugs or ingredients in the investigational drug.
研究者
相似试验
未知
3 期
A phase III study of TAC-202 in patients with perennial or seasonal allergic rhinitis.Patients with perennial or seasonal allergic rhinitis.JPRN-jRCT2080222571Taiho Pharmaceutical Co., Ltd.120
进行中（未招募）
1 期
Study to evaluate the long term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder.EUCTR2017-000918-36-GBAlkermes Inc500
进行中（未招募）
1 期
Study to evaluate the long term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder.EUCTR2017-000918-36-IEAlkermes Inc500
进行中（未招募）
1 期
Study to evaluate the long term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder.EUCTR2017-000918-36-ATAlkermes Inc500
进行中（未招募）
1 期
Study to evaluate the long term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder.EUCTR2017-000918-36-BGAlkermes Inc500